Press release
Kipuwex and IDE Group Collaborate to Develop Next Generation Telehealth Solutions for Enhancing Remote Patient Care
Kipuwex Ltd, a Finnish technology company, and IDE Group, an Australian consultancy and venture builder delivering medtech innovations, are pleased to announce that they have formed a strategic partnership. Kipuwex and IDE Group will collaborate closely towards developing and bringing innovative telehealth solutions to healthcare providers and customers globally.The demand for healthcare services and technologies reached an all-time high in the wake of the COVID-19 pandemic. The potential of telehealth has been emphasised given a global shortage in hospital beds and healthcare workers, creating a once in a generation opportunity to modernise healthcare systems around the world. The telehealth market size is valued at US$49.8 billion and will increase to US$266.8 billion in 2026, with a CAGR of 23.4%.1
The Kipuwex-IDE Group partnership will build on Kipuwex’s easily attachable, light weight Internet of Medical Things (IoMT) device which wirelessly and continuously measures clinically relevant biomarkers vital to the assessment of human well-being and disease management to facilitate real-time data collection, improve remote patient care, enhance clinical workflows and increase healthcare provider efficiency.
IDE Group’s entrepreneurial partnership will help Kipuwex develop and commercialise a differentiated telehealth offering delivering meaningful healthcare outcomes in Europe, the Asia Pacific region and globally.
"In today's competitive environment, collaboration is the enabler for the success of the company. Through collaboration with IDE Group we can achieve a common goal, which is to improve healthcare worldwide by providing reliable and affordable telehealth solutions,” said Kipuwex CEO Marko Höynälä.
“This collaboration provides IDE Group with a great opportunity to bring its entrepreneurial values, MedTech hardware design & development expertise, and proven track record in creating value in new ventures, together with Kipuwex’s exciting portfolio of product, telehealth expertise and deep in-market relationships to improve healthcare outcomes worldwide,” added IDE Group Managing Director George Sidis.
This partnership aligns with IDE Group’s strategic pillars. “There are four main areas where we partner and invest in based on our expertise; wearable therapeutic and diagnostic monitoring devices, drug delivery, surgical instruments, and diagnostics. This collaboration aligns with our particular knowledge and expertise to add value,” noted Mr Sidis.
Kipuwex and IDE Group expect to launch their innovative telehealth offering in the next two to three years.
Available for interview:
IDE Group Managing Director George Sidis. To arrange an interview please contact +61421 592 564.
Reference:
1. Telehealth market size, share, growth | global industry research report, 2019-2026 (last accessed 22 March 2021;
https://www.360researchreports.com/telehealth-market-15633617) pain is a lobal problem - adult.
I D & E Pty Ltd
701-703 Parramatta Rd
Leichhardt NSW 2040
Australia
Media contact: please call +61421592564
About: At IDE Group, we love working together to build better futures. We are an entrepreneurial partner that discovers and develops meaningful offerings that businesses can be built around. We work with our partner organisations to find and assess business opportunities, conduct research, create and implement commercial strategy, gain access to funding, develop new technology, and create successful medtech ventures. Since 2003, IDE has grown over 100 medical technology businesses, and realised over 500 projects across the medical technology landscape including: diagnostics, drug delivery, respiratory care, radiology, radiotherapy, surgical tools and equipment, wearable therapeutic, and diagnostic monitoring devices.
Kipuwex is a pioneer in remote monitoring and pain monitoring. The system comprises of integrated biomarkers, proprietary algorithms and relevant mobile/Web/Cloud services. Over the last 3+ years from its humble beginnings, we are changing how healthcare industry ‘monitors and tracks’ patients’ ecosystem incl. patients, doctors, nurses, ambulances, home care and elderly care.
Our ability to ‘remote-monitor’ especially during Covid-19 as well as the cost-effective, yet most innovative solutions, position us at the global forefront of the medical IoMT industry. Our solution plays an important role in revolutionizing the telehealth industry towards a more patient- centred-approach. Kipuwex’s vision is to become a world leading company in remote monitoring and pain management.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kipuwex and IDE Group Collaborate to Develop Next Generation Telehealth Solutions for Enhancing Remote Patient Care here
News-ID: 2275764 • Views: …
More Releases from IDE Group

IDE Group Reveals Award Winner for Building Better Futures for Health Challenge …
IDE Group, an entrepreneurial commercialisation company that develops medical products and builds market-leading medtech businesses, announced Misti as the winner of the Building Better Futures for Health (BBFH) Challenge 2022 and the People's Choice Award.
The prestigious BBFH Challenge brought together healthcare entrepreneurs, startups, researchers and industry professionals for the first time since the pandemic's onset for an in-person event at the Powerhouse Museum on 21st of September.
Misti, awarded the major…

Building Better Futures for Health Challenge 2022 - Applications Now Open
EMBARGOED TUESDAY 7 JUNE 2022, 5AM AEST
WIN UP TO $30,000 IN IDE GROUP SERVICES
Do you have an idea for a healthcare product or medical technology that can improve and change people's lives?
Entrepreneurs, startups, researchers and industry professionals worldwide are invited to apply for the Building Better Futures for Health (BBFH) Challenge. The winners receive up to $30,000 in entrepreneurial, commercialisation and medical technology development support from IDE Group, bringing your…